Isolation of novel vims-like sequences associated with human hepatitis

Nature Medicine

Volumn 1, Issue 6, 1995, Pages 564-569

  Simons, John N ^a   Leary, Thomas P ^a   Dawson, George J ^a   Pilot Matias, Tami J ^a   Muerhoff, A Scott ^a   Schlauder, George G ^a   Desai, Suresh M ^a   Mushahwar, Isa K ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FLAVIVIRUS; HUMAN; PRIORITY JOURNAL; RNA SEQUENCE; VIRUS HEPATITIS;

ADULT; AFRICA, EASTERN; AFRICA, WESTERN; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; BASE SEQUENCE; CANADA; COMORBIDITY; COMPARATIVE STUDY; DNA HELICASES; FEMALE; FLAVIVIRIDAE; HEPATITIS VIRUSES; HEPATITIS, VIRAL, HUMAN; HUMAN; MALE; MASS SCREENING; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL NONSTRUCTURAL PROTEINS; VIREMIA;

EID: 0029074531     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0695-564     Document Type: Article

References (47)

1. Kuo, G. et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244, 362-364 (1989).
2. Dawson, G.J. etal. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J. Virol. Methods 38, 175-186 (1992).
3. Schlauder, G.G. & Mushahwar, I.K. Detection of hepatitis C and E vims by the polymerase chain reaction. J. Virol. Methods 47, 243-253 (1994).
4. Hollinger, F.B. et al. Transfusion-transmitted viruses study: Experimental evidence for two non-A, non-B hepatitis agents. J. infect. Dis. 142, 400-407 (1980).
5. Brotman, B., Prince, A.M., & Huima, T., Non-A, non-B hepatitis vims: Is there more than a single blood-borne strain? J. infect. Dis. 151, 618-625 (1985).
6. Tabor, E., April, M., Seef, L.B. St Gerety, R.J. Acquired immunity to human nonA, non-B hepatitis: Cross-challenge of chimpanzees with three infectious human sera. J. infect. Dis. 40, 789-793 (1979).
7. Yoshizawa, H. et al. Demonstration of two different types of non-A, non-B hepatitis by reinjection and cross-challenge studies in chimpanzees. Gastroenterology81, 107-113 (1981).
8. Bradley, D.W. et al. Posttransfusion non-A, non-B hepatitis: Physiochemical properties of two distinct agents. J. infect. Dis. 148, 254-265 (1983).
9. Peters, T. et al Frequency of hepatitis C in acute post-transfusion hepatitis after open-heart surgery: A prospective study in 1, 476 patients, J. med. Virol. 39, 139-145 (1993).
10. Alter, H.J. Transfusion transmitted hepatitis C and non-A, non-B, non-C. Vox Sang. 67, 19-24 (1994).
11. Deinhardt, F., Holmes, A.W., Capps, R.B. & Popper, H. Studies on the transmission of disease of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passage and description of liver lesions. J. exp. Med. 125, 673-687 (1967).
12. Holmes, A.W, et al. Specific neutralization of human hepatitis type A in marmoset monkeys. Nature 243, 419-420 (1973).
13. Deinhardt, F., Peterson, D., Cross, G., Wolfe, L. & Holmes, A.W. Hepatitis in marmosets. Am. J. med. Sci. 270, 73-80 (1975).
14. Tabor, E., Seeff, L.B. & Gerety, RJ. Lack of susceptibility of marmosets to human non-A, non-B hepatitis. J. infect. Dis. 140, 794-797 (1979).
15. Tabor, E., Peterson, D.A., April, M., Seeff, L.B. & Gerety, R.J. Transmission of human non-A, non-B hepatitis to chimpanzees following failure to transmit GB agent hepatitis. J. med. Viml. 5, 103-108 (1980).
16. Feinstone, S.M. et al. Non-A, non-B hepatitis in chimpanzees and marmosets. J. infect. Dis. 144, 588-598 (1981).
17. Whittington, R.O., Decker, R.H., Ling, C.-M. Et Overby, L.R. in Viral and Immunological Diseases in Nonhuman Primates (ed. Kalter, S.S.) 221-224 (Liss, New York, 1983).
18. Karayiannis, P. et al. Studies of GB hepatitis agent in tamarins. Hepatology 9, 186-192 (1989).
19. Ticehurst, J. in Viral Hepatitis and Liver Disease (eds Hollinger, F.B., Lemon, S.M. & Margolis, H.S.) 501-513 (Williams & Wilkins, Baltimore, 1991).
20. Purcell, R.H. The discovery of the hepatitis viruses. Gastroenterology 104, 955-963 1993
21. Simons, J.N. et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc. natn. Acad. Sci. U.SA. 92, 3401-3405 (1995).
22. Schlauder, G.G. et al. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J. med. Virol. 46, 81-90 (1995).
23. Hibbs, J.R. etal. Aplastic anemia and viral hepatitis: Non-A, non-B, non-C? JAMA 267, 2051-2054 (1992).
24. Sakamoto, M. etal. Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a. J. gen. Virol. 75, 1761-1768 (1994).
25. Stuyver, L. et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J. gen. Virol. 74, 1093-1102 (1993).
26. Sugitani, M., Inchauspe, G., Shindo, M. St Prince, A.M. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet 339, 1018-1019 (1992).
27. Simmonds, P. et al. Classification of hepatitis C vims into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. gen. Virol. 74, 2391-2399 (1993).
28. Bukh, J., Purcell, R. H., Et Miller, R. H., At least 12 genotypes hepatitis C vims predicted by sequence analysis of the putative El gene of isolates collected worldwide. Proc. natn. Acad. Sci. U.SA. 90, 8234-8238.
29. Iwarson, S. The natural course of chronic hepatitis C. FEMS Microbiol. Rev. 14, 201-204 (1994).
30. Cha, T.-A. etal. Use of a signature nucleotide sequence of hepatitis C vims for detection of viral RNA in human serum and plasma. J. clin. Microbiol. 29, 2528-2534(1991).
31. Bolling, T.J. St Mandecki, W. An Escherichia coli expression vector for high-level production of heterologous proteins in fusion with CMP-KDO synthetase. Bio/Techniques 8, 488-190 (1990).
32. Paul, D.A. et al. Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides. J. infect. Dis. 169, 801 806 1993
33. Roux, K.H. Using mismatched primer-template pairs in touchdown PCR. Bio/Techniques 16, 812-814 (1994).
34. Felsenstein, J. PHYLIP inference package, version 3.5c (Distributed by the author, Dept, of Genetics, University of Washington, Seattle, 1993).
35. Choo, Q.-L. et al. Genetic organization and diversity of the hepatitis C vims. Proc. natn. Acad. Sci. U.SA. 88, 2451-2455 (1991).
36. Okamoto, H. et al. Nucleotide sequences of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions. J. gen. Virol. 72, 2697-2704 (1991).
37. Okamoto, H. et al. Full-length sequence of a hepatitis C vims genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology 188, 331-341 (1992).
38. Meyers, G., Ruemenapf, T. & Thiel, H.-J. Molecular cloning and nucleotide sequence of the genome of hog cholera vims. Virology 171, 555-567 (1989).
39. Collett, M.S. et al. Molecular cloning and nucleotide sequence of the pestivims bovine viral diarrhea vims. Virology 165, 191-199 (1989).
40. Sumiyoshi, H. et al. Complete nucleotide sequence of the Japanese encephalitis vims genome RNA. Virology 161, 497-510 (1987).
41. Dupuy, A., Despres, P., Cahour, A., Girard, M. Sr Bouloy, M. Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccines. Nucleic Adds Res. 17, 3989-3989 (1989).
42. Castle, E., Leidner, U., Nowak, T. & Wengler, G. Primary structure of the West Nile flavivims genome region coding for all nonstmctural proteins. Virology 149, 10-26 (1986).
43. Fu, J., Tan, B.-H., Yap, E.-H., Chan, Y.-C. & Tan, Y.H. Full-length cDNA sequence of dengue type 1 vims (Singapore strain S275/90). Virology 188, 953-958 (1992).
44. Irie, K., Mohan, P.M., Sasaguri, Y., Putnak, R. Et Padmanabhan.R. Sequence analysis of cloned dengue vims type 2 genome (New Guinea-C strain). Gene 75, 197-211 (1989).
45. Bukh, J., Purcell, R.H. Et Miller R.H. Importance of primer selection for the detection of hepatitis C vims RNA with the polymerase chain reaction assay. Proc. natn. Acad. Sd. USA. 89, 187-191 (1992).
46. I. Han, J.H. et al. Characterization of the terminal regions of hepatitis C viral RNA: Identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. Proc. natn. Acad. Sd. U.SA. 88, 1711-1715 (1991).
47. Koonin, E.V., St Dolja, V.V. Evolution and taxonomy of positive-strand RNA viruses: Implications of comparative analysis of amino add sequences. Crit Rev. Biochem. mol. Biol. 28, 375-430 (1993).